Article
Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.
The Annals of thoracic surgery - 1 Jun 2018
Hayasaka Kazuki, Shiono Satoshi, Matsumura Yuki, Yanagawa Naoki, Suzuki Hiroyuki, Abe Jiro, Sagawa Motoyasu, Sakurada Akira, Katahira Masato, Takahashi Satomi, Endoh Makoto, Okada Yoshinori
Abstract excerpt
BACKGROUND: The presence of epidermal growth factor receptor (EGFR) mutations is an established prognostic factor for patients with advanced lung adenocarcinoma. Here, we examined whether EGFR mutation status is a prognostic factor for patients who had undergone surgery. METHODS: Clinicopathologic data from 1,463 patients who underwent complete surgical resection for lung adenocarcinoma between 2005 and 2012 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
